NDC11 70720010025
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70720-0100-25 | 70720-0100 |
| 70720-100-25 | 70720-100 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | TerSera Therapeutics LLC | f33e859d-ebc9-4d4f-a57d-204c48760d20 | 2026-03-04 | Warnings, Adverse reactions | 70720-100-25 70720-100 70720010025 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.